Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
09:00-09:20 | 09:00-09:20 |
The Pathophysiology of AF and HF: The Cause or Effect? |
Jingmin Zhou | Zhongshan Hospital,Fudan University |
09:20-09:40 | 09:20-09:40 |
Current Evidence of AF Ablation in Patients with EFrHF |
Hailong Tao | The First Affiliated Hospital of Zhengzhou University |
09:40-10:00 | 09:40-10:00 |
AF Burden as the New Endpoint: Insights from CASTLE-AF |
Christian Sohns | Herz- und Diabeteszentrum Nordrhein-Westfalen |
10:00-10:20 | 10:00-10:20 |
Moving Forward: CASTLE-AF II |
Nassir Marrouche | Tulane University |
10:20-10:30 | 10:20-10:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
16:00-16:20 | 16:00-16:20 |
Prevalence of Heart Failure and Left Ventricular Dysfunction in China: the China Hypertension Survey, 2012-2015 |
Runlin Gao | FUWAI HOSPITAL,CAMS&PUMC |
16:20-16:40 | 16:20-16:40 |
Opportunities and Challenges in the Treatment of Heart Failure in China |
Liwen Li | Guangdong Provincial People's Hospital |
16:40-17:00 | 16:40-17:00 |
Comorbidities in Heart Failure |
Andrew J Coats | University of Warwick |
17:00-17:20 | 17:00-17:20 |
Treatment of Heart Failure and Valve Disease |
Marco Metra | Cardiology University of Brescia |
17:20-17:30 | 17:20-17:30 |
Discussion |